Aspherical Lenslet Spectacles Slow Myopia Progression in US Children

This randomized clinical trial compared spectacle lenses with highly aspherical lenslets (HAL) to single-vision lenses (SVL) in US children aged 6 to 12 with myopia, following 159 participants over 24 months. The trial reported a 71% relative reduction in myopia progression and a 53% relative reduction in axial elongation with HAL compared to SVL, with equivalent visual acuity between groups and no serious or lens-related adverse events. The authors state these findings support HAL as a safe and effective myopia control intervention and underlie FDA authorization of the study device, though they note longer-term data are needed to evaluate sustained efficacy.

Most relevant for: Children aged 6 to 12 years with myopia in the -0.75 to -4.50 diopter range being considered for myopia control interventions.

Summary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.

Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.